Infections in the era of immunobiologicals
Abstract Immunobiologicals represent an innovative therapeutic option in dermatology. They are indicated in severe and refractory cases of different diseases when there is contraindication, intolerance, or failure of conventional systemic therapy and in cases with significant impairment of patient q...
Saved in:
Main Authors: | Ricardo Romiti (Author), André Luís da Silva Hirayama (Author), Adriana Maria Porro (Author), Heitor de Sá Gonçalves (Author), Luciane Donida Bartoli Miot (Author), Sandra Maria Barbosa Durães (Author), Silvio Alencar Marques (Author) |
---|---|
Format: | Book |
Published: |
Sociedade Brasileira de Dermatologia,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic response and survival time of immunobiologicals in patients with moderate to severe psoriasis
by: Cynthia Cristina Ferreira Mota, et al.
Published: (2022) -
Você conhece esta síndrome? Do you know this syndrome?
by: Sílvio Alencar Marques, et al.
Published: (2005) -
Psoriasis comorbidities: complications and benefits of immunobiological treatment
by: André Vicente Esteves de Carvalho, et al.
Published: (2016) -
Time needed to schedule dermatological consultations in Brazil
by: Hélio Amante Miot, et al.
Published: (2013) -
Psoriasis: correlation between severity index (PASI) and systemic treatment
by: Maria Flavia Pereira da Silva, et al.
Published: (2013)